Search Results - "Geruntho, Jonathan J."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Tunable pH-Sensitive Linker for Controlled Release by Choy, Cindy J, Geruntho, Jonathan J, Davis, Austen L, Berkman, Clifford E

    Published in Bioconjugate chemistry (16-03-2016)
    “…We have developed a novel pH-sensitive linker based on a phosphoramidate scaffold that can be tuned to release amine-containing drug molecules at various pH…”
    Get full text
    Journal Article
  2. 2

    Silica nanostructured platform for affinity capture of tumor-derived exosomes by Ziaei, Parissa, Geruntho, Jonathan J., Marin-Flores, Oscar G., Berkman, Clifford E., Grant Norton, M.

    Published in Journal of materials science (01-06-2017)
    “…Early diagnosis of prostate cancer and evaluation of appropriate treatment options requires development of effective and high-throughput selective capture…”
    Get full text
    Journal Article
  3. 3

    Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release by Choy, Cindy J., Ley, Corinne R., Davis, Austen L., Backer, Brian S., Geruntho, Jonathan J., Clowers, Brian H., Berkman, Clifford E.

    Published in Bioconjugate chemistry (21-09-2016)
    “…We developed a second generation of tunable pH-sensitive linkers based on our phosphoramidate scaffold to release amine-containing drugs under acidic…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    177 Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice by Choy, Cindy J, Ling, Xiaoxi, Geruntho, Jonathan J, Beyer, Sophia K, Latoche, Joseph D, Langton-Webster, Beatrice, Anderson, Carolyn J, Berkman, Clifford E

    Published in Theranostics (2017)
    “…Prostate-specific membrane antigen (PSMA) continues to be an active biomarker for small-molecule PSMA-targeted imaging and therapeutic agents for prostate…”
    Get full text
    Journal Article
  9. 9

    Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells by Wu, Lisa Y., Johnson, Jacqueline M., Simmons, Jessica K., Mendes, Desiree E., Geruntho, Jonathan J., Liu, Tiancheng, Dirksen, Wessel P., Rosol, Thomas J., Davis, William C., Berkman, Clifford E.

    Published in The Prostate (01-05-2014)
    “…BACKGROUND Prostate‐specific membrane antigen (PSMA) remains an important target for diagnostic and therapeutic application for human prostate cancer. Model…”
    Get full text
    Journal Article
  10. 10

    177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice by Choy, Cindy J., Ling, Xiaoxi, Geruntho, Jonathan J., Beyer, Sophia K., Latoche, Joseph D., Langton-Webster, Beatrice, Anderson, Carolyn J., Berkman, Clifford E.

    Published in Theranostics (27-04-2017)
    “…Prostate-specific membrane antigen (PSMA) continues to be an active biomarker for small-molecule PSMA-targeted imaging and therapeutic agents for prostate…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled by Choy, Cindy J, Ley, Corinne R, Davis, Austen L, Backer, Brian S, Geruntho, Jonathan J, Clowers, Brian H, Berkman, Clifford E

    Published in Bioconjugate chemistry (21-09-2016)
    “…We developed a second generation of tunable pH-sensitive linkers based on our phosphoramidate scaffold to release amine-containing drugs under acidic…”
    Get full text
    Journal Article
  13. 13
  14. 14